US/UK/Canada

Share

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.

Pick a time period -
Tags ( Active)

Year-end Report, January-December 2015

January-December 2015[1] · Net sales reached SEK 19,648 million (15,352), corresponding to an increase of 28%, 21% at constant exchange rates, compared with the previous year. · EBITDA, excluding non-recurring items, was SEK 6,482 million (4,700), corresponding to an increase of 38%, and a margin of 33.0% (30.6). · Non-recurring items had a SEK 698 million negative impact on earnings before tax. · Profit after tax amounted to SEK 1.192 million (402). · Earnings per share reached SEK 3.22 (1.23)[2]. Excluding non-recurring items, earnings per share totaled SEK 4.14 (3.64)[2].

Year-end report January–December 2013

January-December 2013 · Group net sales reached SEK 13,114 million (12,991), corresponding to organic growth[1] of 4% compared to last year. · EBITDA amounted to SEK 3,734 million (3,945), corresponding to a 28.5% margin (30.4). · Operating profit totaled SEK 1,548 million (1,801). · Profit after tax amounted to SEK 805 million (1,175[2]). · Earnings per share reached SEK 2.67 (3.98[2]). · Cash earnings per share reached SEK 8.89 (8.84). · Proposed dividend per share: SEK 2.50 (2.25). Fourth quarter 2013 · Group net sales reached SEK 3,450 million (3,195).

Invitation to teleconference for analysts, investors and journalists

Presentation of Meda’s Year-End Results 2013On Wednesday, February 19, 2014 at 8:00 CET, Meda will release its year-end results for 2013. Meda invites all analysts, investors and media to a teleconference to be held on Wednesday, February 19 at 10:30 CET. During the teleconference, CEO Jörg-Thomas Dierks and CFO Henrik Stenqvist will present the results of the 2013 year-end report. The year-end report will be available at Meda’s website, www.meda.se. Slides from the presentation will be available at the same address. The webcast presentation can be heard at: http://www.media-server.

Meda AB (publ) – Year-end report, January - December 2012

Full year 2012 · Group net sales reached SEK 12,991 million (12,856). At fixed exchange rates, sales increased 3%. · EBITDA amounted to SEK 3,935 million (4,683), corresponding to a 30.3% margin (36.4). · Operating profit amounted to SEK 1,791 million (2,644). · Profit after tax totaled SEK 1,180 million (1,608). Excluding non-recurring effects, profit after tax totaled SEK 1,001[1]million (1,480[2]). · Earnings per share reached SEK 4.00 (5.35). Excluding non-recurring effects, earnings per share totaled SEK 3.41[1]  (4.93[2] ). · Cash

There are no items matching the current filter
There are no more items matching the current filter
Back to top